Konrad Emil Bloch
Konrad Emil Bloch (January 21, 1912 – October 15, 2000) was a German-American biochemist. He was awarded the Nobel Prize in Physiology or Medicine in 1964, sharing it with Feodor Lynen for their discoveries concerning the mechanism and regulation of the cholesterol and fatty acid metabolism. Bloch's work laid the foundation for understanding the biochemical processes involved in the synthesis of steroid hormones and the metabolism of lipids.
Early Life and Education[edit | edit source]
Konrad Emil Bloch was born in Neisse (now Nysa, Poland), in the German Empire. In 1934, due to the rise of the Nazi regime and the enactment of the Nuremberg Laws, Bloch, who was Jewish, emigrated to Switzerland. He continued his education at the Swiss Federal Institute of Technology in Zurich, where he received his diploma in chemical engineering in 1938. Bloch then moved to the United States, where he earned his Ph.D. in biochemistry from Columbia University in 1942 under the mentorship of Rudolph Schoenheimer, a pioneer in the use of isotopes to trace the metabolism of lipids.
Career and Research[edit | edit source]
After completing his Ph.D., Bloch worked on the Manhattan Project at Columbia University during World War II. In 1946, he joined the faculty of the University of Chicago, where he began his groundbreaking research on lipid metabolism. In 1954, Bloch moved to Harvard University, where he continued his research until his retirement in 1982.
Bloch's most significant contribution to biochemistry was his research on the biosynthesis of cholesterol. He discovered that acetyl-CoA is the building block of cholesterol and elucidated the steps involved in its conversion to cholesterol. This work not only advanced the understanding of cholesterol metabolism but also had implications for the study of steroid hormones and the development of drugs to control cholesterol levels.
Nobel Prize[edit | edit source]
In 1964, Konrad Emil Bloch was awarded the Nobel Prize in Physiology or Medicine along with Feodor Lynen for their discoveries concerning the regulation of the cholesterol and fatty acid metabolism. Their work provided insights into the synthesis of cholesterol, a fundamental biochemical process that has implications for diseases such as atherosclerosis and heart disease.
Later Years and Legacy[edit | edit source]
After retiring from Harvard, Bloch continued to be active in research and education. He was a member of numerous scientific societies and received several awards and honors in addition to the Nobel Prize. Bloch's legacy is not only in his scientific discoveries but also in his role as a mentor to future generations of scientists.
Konrad Emil Bloch passed away on October 15, 2000, in Lexington, Massachusetts. His work remains a cornerstone of biochemistry and lipid metabolism research, influencing the fields of medicine, nutrition, and pharmacology.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD